Anna-Lena Spetz

Anna-Lena Spetz

Company: TIRmed Pharma

Job title: Chief Scientific Officer & Founder


Immunoregulatory Oligonucleotide for the Treatment of Mild- Moderate Atopic Dermatitis. 11:15 am

Developing a non-steroid topical treatment in a small biotech:-possibilities and challenges Inducing immunoregulatory type immune responses in the skin to enhance preclinical modelling Reducing certain itch responses by an immunoregulatory oligonucleotideRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.